Repetitive saliva swallowing test and water swallowing test may identify a COPD phenotype at high risk of exacerbation.


Journal

The clinical respiratory journal
ISSN: 1752-699X
Titre abrégé: Clin Respir J
Pays: England
ID NLM: 101315570

Informations de publication

Date de publication:
May 2019
Historique:
received: 27 09 2018
revised: 16 01 2019
accepted: 24 02 2019
pubmed: 2 3 2019
medline: 7 1 2020
entrez: 2 3 2019
Statut: ppublish

Résumé

Patients with chronic obstructive pulmonary disease (COPD) are known to present with dysphagia from an early stage. Dysphagia leads to swallowing-related complications, in turn leading to COPD exacerbation. Dysphagia screening is recommended; however little is known of its utility in detecting a COPD phenotype at risk for exacerbation. The simple swallowing provocation test (SSPT), considered to be a standard screening test, requires specific equipment, physician skill and patient discomfort. The aim of this study was to find an easier and less invasive measure to screen for dysphagia in patients with COPD. We retrospectively reviewed patients with COPD who were screened for dysphagia [Repetitive saliva swallowing test (RSST), water swallowing test (WST), SSPT and a questionnaire] from June to November 2016. The patients were classified into two groups according to the presence of COPD exacerbation in the past 3 years (ie, exacerbation and non-exacerbation group), and the dysphagia screening results were compared between the groups. Of the 80 cases included, 42 had 1 or more exacerbations in the past 3 years (exacerbation group), and 38 had none (non-exacerbation group). Statistically significant differences between the groups were observed in the RSST, and vocal change in the WST (P < 0.05). There were no significant differences between the groups in the results of SSPT, COPD stage and other clinical status. Compared to the SSPT, RSST and WST may be more appropriate screening methods in patients with COPD. A prospective study is necessary for further assessment.

Identifiants

pubmed: 30821113
doi: 10.1111/crj.13014
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

321-327

Subventions

Organisme : Iizuka Hospital

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Yuki Yoshimatsu (Y)

Department of Respiratory Medicine, Iizuka Hospital, Fukuoka, Japan.

Kazunori Tobino (K)

Department of Respiratory Medicine, Iizuka Hospital, Fukuoka, Japan.
Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Takuto Sueyasu (T)

Department of Respiratory Medicine, Iizuka Hospital, Fukuoka, Japan.

Saori Nishizawa (S)

Department of Respiratory Medicine, Iizuka Hospital, Fukuoka, Japan.

Yuki Goto (Y)

Department of Respiratory Medicine, Iizuka Hospital, Fukuoka, Japan.

Kojin Murakami (K)

Department of Respiratory Medicine, Iizuka Hospital, Fukuoka, Japan.

Miyuki Munechika (M)

Department of Respiratory Medicine, Iizuka Hospital, Fukuoka, Japan.

Kohei Yoshimine (K)

Department of Respiratory Medicine, Iizuka Hospital, Fukuoka, Japan.

Hiroyuki Miyajima (H)

Department of Respiratory Medicine, Iizuka Hospital, Fukuoka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH